Moneycontrol PRO
HomeNewsBusinessDr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher

Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher

Net Sales are expected to increase by 26.8 percent Y-o-Y (down 9.7 percent Q-o-Q) to Rs 547.6 crore, according to Prabhudas Lilladher.

October 06, 2021 / 17:39 IST
Dr Lal Pathlabs 

Dr Lal Pathlabs 

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Dr. Lal PathLabs to report net profit at Rs 112 crore up 28.4% year-on-year (up 16.2% quarter-on-quarter).

Net Sales are expected to increase by 26.8 percent Y-o-Y (down 9.7 percent Q-o-Q) to Rs 547.6 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 24.8 percent Y-o-Y (down 16 percent Q-o-Q) to Rs 158.8 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Oct 6, 2021 05:39 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347